Natural Killer Cell TGF-β Signaling Regulates Postnatal Lung Development
Declan J. Gainer, Kassandra M. Coyle, Matthew T. Rätsep, Douglas Quilty, Brian L. Tran Van, Sofia Skebo, M. Martin VandenBroek, Kimberly J. Laverty, Yupu Deng, Jenna F. Alalouf, Shawyon P. Shirazi, Hugh J.M. Brady, Jennifer M.S. Sucre, Eric Vivier, Niraj Shrestha, Hing C. Wong, Duncan J. Stewart, Nicolle J. Domnik, Mark L. OrmistonBACKGROUND:
Bronchopulmonary dysplasia (BPD) is a disease of neonatal lung development that is linked to impaired pulmonary vascularization, dysregulated TGF-β (transforming growth factor-β) signaling, and the accumulation of senescent cells. Despite the established role of TGF-β signaling in promoting vascular remodeling and suppressing the senolytic activity of natural killer (NK) cells, the contribution of NK cell TGF-β signaling to postnatal lung patterning and the pathogenesis of BPD remains unclear.
METHODS:
Mice bearing an NK cell-selective deletion of the type-II TGF-β receptor (
RESULTS:
Neonatal
CONCLUSIONS:
TGF-β is a tunable regulator of NK cell senolytic activity that is essential for normal postnatal lung development. Excessive NK cell TGF-β signaling contributes to impaired lung development with neonatal hyperoxia and may serve as a viable therapeutic target in human BPD.